JCIA
TBPH icon

Jackson Creek Investment Advisors’s Theravance Biopharma TBPH Stock Holding History

Jackson Creek Investment Advisors’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.92M Buy
+118,560
New +$2.1M 0.57% 39

Other funds holding TBPH

MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ICM
Irenic Capital Management New York $1.54B AUM 12.79% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jackson Creek Investment Advisors's TBPH Position: Q1 2026 in Review

Jackson Creek Investment Advisors opened a new position in Theravance Biopharma (TBPH) in Q1 2026: 118,560 shares worth $1.92M. The stake represents 0.57% of the portfolio and ranks #39 among its holdings.

173 funds tracked by Wall St. Rank hold TBPH as of Q1 2026.

  • Jackson Creek Investment Advisors held 118,560 shares of Theravance Biopharma worth $1.92M as of Q1 2026.
  • Theravance Biopharma was a new Jackson Creek Investment Advisors position in Q1 2026.
  • Theravance Biopharma made up 0.57% of Jackson Creek Investment Advisors's portfolio in Q1 2026, its #39 holding.
  • 173 funds tracked by Wall St. Rank held Theravance Biopharma as of Q1 2026.

Based on Jackson Creek Investment Advisors's 13F filing for Q1 2026, filed 5 May 2026.